Showing 1 to 10 of 19 clinical trials
1 | 2 |
CLINICAL TRIALS
    Trial No
    ClinicalTrials.gov ID
Phase Coordinator
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
    COG-ACNS1831
    NCT03871257
     Recruiting
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
Linda Hershon
514-345-4931 poste 5899
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
    ACNS2021
    NCT04684368
     Recruiting
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
Clemence Noury
514-345-4931 poste 6848
A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
    Orbus OT-15-0011
    NCT02796261
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
Phase III Gabriele Riva
514-398-6907
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
    NRG-BN003
    NCT03180268
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Phase III Ginette Ricard
514-934-1934 poste 43186
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
    ACNS2021
    NCT04684368
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
Jessica David
514-412-4400 poste 22245
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
    COG-ACNS1831
    NCT03871257
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
Stephanie Badour
514-412-4400 poste 23807
Phase III Randomized Double-blind Placebo-controlled Trial of Metformin for Cognitive Recovery and White Matter Growth in Paediatric Medulloblastoma Patients
    Met Med Can
    NCT05230758
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
Stephanie Badour
514-412-4400 poste 23807
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
    CE.7
    NCT03550391
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Evelyn Ortega
514-934-1934 poste 48354
A Phase 3 Study of Selumetinib or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations
    ACNS1931
    NCT04576117
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
Panagiota Giannakouros
418-525-4444 poste 40121
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
    ACNS2021
    NCT04684368
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
Panagiota Giannakouros
418-525-4444 poste 40121
1 | 2 |